ストックスクリーナーアプリを入手
7.65
2.13%
0.15
前日終値:
$7.50
開ける：
$7.56
24時間の取引高:
811.36K
Relative Volume:
0.75
時価総額：
$586.94M
収益：
$83.57M
当期純損益:
$-4.94M
株価収益率:
-85.00
EPS:
-0.09
ネットキャッシュフロー:
$6.97M
1週間 パフォーマンス:
+6.39%
1か月 パフォーマンス:
+121.39%
6か月 パフォーマンス:
+142.41%
1年 パフォーマンス:
+431.94%
1日の値動き範囲:
$7.37
$7.85
1週間の範囲:
$6.80
$7.85
52週間の値動き範囲:
$1.32
$7.85
Chromadex Corp Stock (CDXC) Company Profile
名前
Chromadex Corp
電話
310-388-6706
住所
10900 WILSHIRE BLVD, LOS ANGELES
CDXC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| CDXC | 7.66 | 586.94M | 83.57M | -4.94M | 6.97M | -0.09 |
| KHC | 31.04 | 37.63B | 26.13B | 1.37B | 3.00B | 2.42 |
| GIS | 63.93 | 35.50B | 19.80B | 2.40B | 2.78B | 4.10 |
| K | 80.96 | 27.75B | 12.80B | 1.01B | 927.00M | 2.50 |
| MKC | 78.02 | 20.91B | 6.68B | 792.60M | 774.40M | 2.40 |
| HRL | 30.52 | 16.61B | 11.98B | 780.78M | 902.87M | 1.61 |
Chromadex Corp Stock (CDXC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-08-16 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-08-11 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | 開始されました | ROTH Capital | Buy |
| 2019-10-16 | 開始されました | Oppenheimer | Outperform |
| 2019-02-14 | 開始されました | B. Riley FBR | Buy |
| 2017-11-27 | 再開されました | H.C. Wainwright | Buy |
| 2017-09-25 | 開始されました | Ladenburg Thalmann | Buy |
| 2017-01-03 | 開始されました | Rodman & Renshaw | Buy |
すべてを表示
Chromadex Corp (CDXC) 最新ニュース
ChromaDex Gears Up to Report Q3 Earnings: Here's What to Expect - MSN
ChromaDex stock soars to 52-week high, hits $7.58 By Investing.com - Investing.com Australia
ChromaDex stock soars to 52-week high, hits $7.58 - Investing.com
ChromaDex Co. (NASDAQ:CDXC) Short Interest Update - MarketBeat
ChromaDex Expands Niagen IV Access to 200+ Restore Hyper Wellness Clinics - Athletech News
, Featured as the Hero Ingredient in Longevity.Technology’s Inaugural Longevity Supplement - Business Wire
ChromaDex (NASDAQ:CDXC) Sets New 12-Month HighHere's Why - MarketBeat
ChromaDex stock soars to 52-week high, hits $7.08 - Investing.com
ChromaDex (NASDAQ:CDXC) Cut to "Buy" at StockNews.com - MarketBeat
What Makes ChromaDex (CDXC) a Strong Momentum Stock: Buy Now? - Yahoo Finance
ChromaDex rolls out Niagen IV at wellness centers By Investing.com - Investing.com Australia
What is Roth Capital's Estimate for ChromaDex Q2 Earnings? - MarketBeat
ChromaDex rolls out Niagen IV at wellness centers - Investing.com India
ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide - Business Wire
Research Analysts Issue Forecasts for ChromaDex Q4 Earnings - MarketBeat
Shareholders Can Be Confident That ChromaDex's (NASDAQ:CDXC) Earnings Are High Quality - Yahoo Finance
ChromaDex (NASDAQ:CDXC) Hits New 12-Month High After Analyst Upgrade - Defense World
ChromaDex's Niagen IV Launches Nationwide: Clinical Data Shows 75% Faster NAD+ Therapy | CDXC Stock News - StockTitan
HC Wainwright Issues Positive Outlook for ChromaDex Earnings - MarketBeat
ChromaDex Corporation (CDXC) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
HC Wainwright Brokers Boost Earnings Estimates for ChromaDex - MarketBeat
ChromaDex records 31% sales growth; stock PT raised to $8 by H.C. Wainwright - Investing.com
Are Investors Keen On Selling Holdings In Chromadex Corp (NASDAQ: CDXC)? - Stocks Register
ChromaDex (NASDAQ:CDXC) Given New $8.00 Price Target at HC Wainwright - MarketBeat
BSW Wealth Partners Acquires Shares of 88,847 ChromaDex Co. (NASDAQ:CDXC) - MarketBeat
Roth Capital Estimates ChromaDex's Q2 Earnings (NASDAQ:CDXC) - MarketBeat
ChromaDex (NASDAQ:CDXC) Releases Quarterly Earnings Results - MarketBeat
ChromaDex Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
ChromaDex Corp (CDXC) Q3 2024 Earnings Call Highlights: Record R - GuruFocus.com
ChromaDex stock soars to 52-week high, hits $4.69 By Investing.com - Investing.com Nigeria
ChromaDex stock soars to 52-week high, hits $4.69 - Investing.com India
ChromaDex (CDXC) Beats Q3 Earnings and Revenue Estimates - MSN
ChromaDex Corp (CDXC) Q3 2024 Earnings: EPS of $0.02 Beats Estimates, Revenue Hits $25.6 Million - GuruFocus.com
ChromaDex Corp (CDXC) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance
ChromaDex surges on surprise Q3 profit - XM
ChromaDex: Q3 Earnings Snapshot - New Haven Register
ChromaDex Reports Strong Q3 2024 Financial Results - TipRanks
ChromaDex Corporation Reports Third Quarter 2024 Financial Results - BioSpace
ChromaDex Shares Climb on Forecast for 15% Revenue Growth - MarketWatch
Chromadex Reports Strong Q3 2024 with 31% Sales Increase - TipRanks
ChromaDex reports Q3 EPS 2c, consensus 0c - TipRanks
ChromaDex sees FY24 revenue growth 15% - TipRanks
ChromaDex Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Curious About NAD+? Here’s How It Works and How to Try It At Home - NewBeauty Magazine
ChromaDex Q3 2024 Earnings Preview - MSN
ChromaDex Corp (CDXC) Q3 2024 Earnings Report Preview: What To E - GuruFocus.com
Insights into ChromaDex's Upcoming EarningsChromaDex (NASDAQ:CDXC) - Benzinga
ChromaDex Co. (NASDAQ:CDXC) Sees Significant Drop in Short Interest - MarketBeat
$9M Fee Awarded For 'Feeble' Milk Vitamin Eligibility Row - Law360
Chromadex Corp (CDXC) 財務データ
収益
当期純利益
現金流量
EPS
Chromadex Corp (CDXC) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Patrick Kristin | Director |
Aug 23 '24 |
Sale |
3.57 |
23,000 |
82,110 |
0 |
0.35%
0.03%
大文字化:
|
ボリューム (24 時間):